Clinical Trial Update: Adrenaline for the Treatment of No-Reflow in Normotensive Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating adrenaline for treating no-reflow in normotensive patients with acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• No-reflow Phenomenon

Drugs mentioned

• Adrenaline (epinephrine)

Snippet

Sponsor: National Institute of Cardiovascular Diseases, Pakistan | Conditions: Acute Coronary Syndrome, No-Reflow Phenomenon | Phase 4 | Status: COMPLETED